Request a demo
Request a demo

Citrix Bleed (CVE-2023-4966): Key Takeaways from Affected Companies

CISA recently issued a critical advisory about the exploitation of the CitrixBleed vulnerability (CVE-2023-4966). Since its discovery, numerous notorious and well-established criminal groups, such as Lockbit and AlphV / BlackCat, have been actively exploiting the vulnerability.  

In this webinar, we will review real-life CitrixBleed exploitations, as investigated by Morphisec's Incident Response (IR) team, illuminating the tactics and techniques used by the threat actors.   

We’ll provide a clear overview of the incidents, from the initial breach to the attempted theft of data, along with practical recommendations to help prevent such security threats. Discover our first-hand insights and learn essential steps to safeguard against this serious cybersecurity issue. 

Watch this on-demand webinar to hear exclusive details, including:  

  • TTPs used by the threat actors 
  • Recommendations to help teams prevent related security threats 


Michael-Gorelik-web2 Michael Gorelik |CTO and Head of Malware Research  

Michael Gorelik is CTO of Morphisec, leading malware research operations and setting the company’s technology strategy. Michael has 20+ years of cybersecurity experience and is a noted industry speaker.  He jointly holds seven patents in the IT space. 

Oren_Square Oren T. Dvoskin | Product Marketing Director – Moderator 

Oren T. Dvoskin is Product Marketing Director at Morphisec, leading the company’s GTM strategy. Oren has 10+ years of Cybersecurity and tech business leadership experience, with a prior extensive career in software R&D.